BIOMAT Database Logo BIOMAT Database Logo

Ontogeny of multiple forms of monoamine oxidase in mouse brain. 1975

F J Chordikian, and B Tabakoff, and S G Alivisatos

MAO activities in mouse brain responsible for deamination of serotonin (5-HT) and p-dimethylaminobenzylamine (DAB) were found to follow different postnatal developmental patterns. MAO activity which deaminated 5-HT reached adult levels 15 days after birth. At this age the capacity of brain to deaminate DAB was only 50% of adult levels and did not develop fully until after the 45th postnatal day. Inhibitor studies with Deprenil and clorgyline indicated that the deamination of the two substrates was due to different forms of MAO and that these forms were similar to type A and type B MAO described previously in rat brain.

UI MeSH Term Description Entries
D008297 Male Males
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003010 Clorgyline An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. Clorgilin,Chlorgyline,Clorgiline
D004124 p-Dimethylaminoazobenzene A reagent used mainly to induce experimental liver cancer. According to the Fourth Annual Report on Carcinogens (NTP 85-002, p. 89) published in 1985, this compound "may reasonably be anticipated to be a carcinogen." (Merck, 11th ed) Butter Yellow,Dimethylaminoazobenzene,4-Dimethylaminoazobenzene,Methyl Yellow,p-Dimethylaminoazobenzene, (E)-Isomer,p-Dimethylaminoazobenzene, (Z)-Isomer,4 Dimethylaminoazobenzene,p Dimethylaminoazobenzene

Related Publications

F J Chordikian, and B Tabakoff, and S G Alivisatos
Multiple forms of rat brain monoamine oxidase.
August 1969, Nature,
F J Chordikian, and B Tabakoff, and S G Alivisatos
[Multiple forms of human brain monoamine oxidase].
January 1981, Voprosy meditsinskoi khimii,
F J Chordikian, and B Tabakoff, and S G Alivisatos
Multiple forms of human brain mitochondrial monoamine oxidase.
February 1970, Nature,
F J Chordikian, and B Tabakoff, and S G Alivisatos
Multiple forms of monoamine oxidase in developing chick brain.
January 1978, Developmental neuroscience,
F J Chordikian, and B Tabakoff, and S G Alivisatos
Multiple forms of monoamine oxidase in the developing brain.
December 1969, Nature,
F J Chordikian, and B Tabakoff, and S G Alivisatos
Development of multiple forms of mouse brain monoamine oxidase in vivo and in vitro.
June 1977, Brain research,
F J Chordikian, and B Tabakoff, and S G Alivisatos
Multiple forms of human brain monoamine oxidase: substrate specificities.
April 1970, The Biochemical journal,
F J Chordikian, and B Tabakoff, and S G Alivisatos
Human brain monoamine oxidase: multiple forms and selective inhibitors.
March 1972, Nature,
F J Chordikian, and B Tabakoff, and S G Alivisatos
Multiple forms of rat brain mitochondrial monoamine oxidase. Subcellular localization.
August 1972, FEBS letters,
F J Chordikian, and B Tabakoff, and S G Alivisatos
Multiple forms of mitochondrial monoamine oxidase.
January 1972, Advances in biochemical psychopharmacology,
Copied contents to your clipboard!